Further, in the immune rich-regions of melanoma, several proteins, including CD19/20, CD8, and CD45RO, are enriched in RECIST responders (Fig. 2d) while for GBM tumors, no measured proteins are enriched in mRs or mNRs (Fig. 2f). Here, CD19 is linked to melanoma.